Dissecting the Novel Molecular Interactions of Solute Carrier Family 4 Member 4 (SLC4A4) for Prostate Cancer (PCa) Progression

Scientists investigated the role of SLC4A4 and the signaling mechanism underlying its role in modulating the prostate cancer progression.